Shanrong Biotechnology Corp. (SRBT)

Shanrong Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2015	FY 2014	FY 2009	FY 2008	FY 2007
Period Ending	Dec 31, 2015	Dec 31, 2014	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Net Income	-0	-0	-5.08	-2.72	-2
Depreciation & Amortization	-	-	0.04	0.04	0.04
Other Amortization	-	-	-	0.03	-
Stock-Based Compensation	-	-	3.38	0.13	1.12
Change in Accounts Receivable	-	-	0.05	0.78	-0.88
Change in Inventory	-	-	0.1	-	-
Change in Accounts Payable	0	0	0.11	0.35	0.14
Change in Unearned Revenue	-	-	-	-0.76	0.76
Change in Other Net Operating Assets	-	-	0.62	0.72	0.14
Operating Cash Flow	-	-	-0.79	-1.46	-0.68
Capital Expenditures	-	-	-	-0	-
Investing Cash Flow	-	-	-	-0	-
Short-Term Debt Issued	-	-	0.23	1.12	1.99
Long-Term Debt Issued	-	-	0	1.13	-
Total Debt Issued	-	-	0.23	2.25	1.99
Short-Term Debt Repaid	-	-	-0	-0.11	-1.18
Long-Term Debt Repaid	-	-	-0.11	-1.03	-0.12
Total Debt Repaid	-	-	-0.11	-1.14	-1.3
Net Debt Issued (Repaid)	-	-	0.12	1.11	0.69
Issuance of Common Stock	-	-	0.64	0.4	-
Other Financing Activities	-	-	-	-0.03	-
Financing Cash Flow	-	-	0.76	1.48	0.69
Net Cash Flow	-	-	-0.03	0.03	0.01
Free Cash Flow	-	-	-0.79	-1.46	-0.68
Free Cash Flow Margin	-	-	-59.44%	-210.28%	-90.59%
Free Cash Flow Per Share	-	-	-2.44	-4.58	-2.64
Cash Interest Paid	-	-	0.03	0.08	0.1
Levered Free Cash Flow	-	-	0.88	-0.44	0.07
Unlevered Free Cash Flow	-	-	1.05	-0.27	0.14
Change in Net Working Capital	-	-	-0.64	-1.08	-0.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.